Generics in Europe
Description
Generics>in>Europe
Summary
>Generics>in>Europe>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>size>(value>and>volume>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
Summary
>Generics>in>Europe>industry>profile>provides>top-line>qualitative>and>quantitative>summary>information>including:>market>size>(value>and>volume>2019-24,>and>forecast>to>2029).>The>profile>also>contains>descriptions>of>the>leading>players>including>key>financial>metrics>and>analysis>of>competitive>pressures>within>the>market.
Key>Highlights
- A>generic>drug>is>defined>as>a>copy>of>an>ethical>(prescription)>drug>formerly>protected>by>patents>that>have>now>expired.>Both>unbranded>generics>and>branded>generics>are>included>in>our>market>scope.>However,>off-patent>drugs>that>continue>to>be>offered>by>the>original>manufacturer>under>the>original>name,>and>which>form>part>of>the>'generic-eligible'>market,>are>not>included.>Market>value>is>evaluated>at>ex-factory>prices.>Market>volume>refers>to>the>proportion>of>the>total>ethical>pharmaceutical>market>in>a>country>or>region>that>is>made>up>of>generic>drugs.>Thus,>it>is>a>measure>of>the>market>share>held>by>generics,>rather>than>a>direct>measure>of>the>total>market>volume.>Regional>volumes>are>calculated>as>averages>of>countries>that>comprise>the>region>where>volume>data>exists.
- The>European>generics>market>recorded>revenues>of>$102.7>billion>in>2024,>representing>a>compound>annual>growth>rate>(CAGR)>of>5.8%>between>2019>and>2024.
- Market>consumption>volume>increased>with>a>CAGR>of>1.5%>between>2019>and>2024,>reaching>a>total>of>55.6>%>of>total>pharma>volume>in>2024.
- In>2024,>the>revenue>of>the>European>generics>market>experienced>an>annual>growth>of>5.9%.>The>market’s>growth>is>driven>by>the>rising>prevalence>of>chronic>diseases>such>as>diabetes,>hypertension,>and>cardiovascular>conditions,>increasing>the>demand>for>affordable,>long-term>medications.
- Save>time>carrying>out>entry-level>research>by>identifying>the>size,>growth,>major>segments,>and>leading>players>in>the>generics>market>in>Europe
- Use>the>Five>Forces>analysis>to>determine>the>competitive>intensity>and>therefore>attractiveness>of>the>generics>market>in>Europe
- Leading>company>profiles>reveal>details>of>key>generics>market>players’>global>operations>and>financial>performance
- Add>weight>to>presentations>and>pitches>by>understanding>the>future>growth>prospects>of>the>Europe>generics>market>with>five>year>forecasts>by>both>value>and>volume
- What>was>the>size>of>the>Europe>generics>market>by>value>in>2024?
- What>will>be>the>size>of>the>Europe>generics>market>in>2029?
- What>factors>are>affecting>the>strength>of>competition>in>the>Europe>generics>market?
- How>has>the>market>performed>over>the>last>five>years?
- What>are>the>main>segments>that>make>up>Europe's>generics>market?
Table of Contents
50 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. Have there been any recent developments in the market?
- 8 Company Profiles
- 8.1. Teva Pharmaceutical Industries Ltd
- 8.2. Novartis AG
- 8.3. Sandoz Group AG
- 8.4. Hikma Pharmaceuticals Plc
- 8.5. Sanofi
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Europe generics market value: $ million, 2019-24
- Table 2: Europe generics market volume: % of total pharma volume, 2019-24
- Table 3: Europe generics market geography segmentation: $ million, 2024
- Table 4: Europe generics market value forecast: $ million, 2024-29
- Table 5: Europe generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
- Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
- Table 9: Novartis AG: Key Facts
- Table 10: Novartis AG: Annual Financial Ratios
- Table 11: Novartis AG: Key Employees
- Table 12: Sandoz Group AG: Key Facts
- Table 13: Sandoz Group AG: Annual Financial Ratios
- Table 14: Sandoz Group AG: Key Employees
- Table 15: Hikma Pharmaceuticals Plc: Key Facts
- Table 16: Hikma Pharmaceuticals Plc: Annual Financial Ratios
- Table 17: Hikma Pharmaceuticals Plc: Key Employees
- Table 18: Sanofi: Key Facts
- Table 19: Sanofi: Annual Financial Ratios
- Table 20: Sanofi: Key Employees
- Table 21: Sanofi: Key Employees Continued
- Table 22: Europe Size of Population (Million), 2020-24
- Table 23: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 24: Europe GDP (Current Prices, $ Billion), 2020-24
- Table 25: Europe Inflation, 2020-24
- Table 26: Europe Consumer Price Index (Absolute), 2020-24
- Table 27: Europe Exchange Rate, 2019-24
- List of Figures
- Figure 1: Europe generics market value: $ million, 2019-24
- Figure 2: Europe generics market volume: % of total pharma volume, 2019-24
- Figure 3: Europe generics market geography segmentation: % share, by value, 2024
- Figure 4: Europe generics market value forecast: $ million, 2024-29
- Figure 5: Europe generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in Europe, 2024
- Figure 7: Drivers of buyer power in the generics market in Europe, 2024
- Figure 8: Drivers of supplier power in the generics market in Europe, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Europe, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in Europe, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in Europe, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


